Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19

OBJECTIVE: The study aimed to report the efficacy and safety of anakinra treatment in patients with the refractory multisystemic inflammatory syndrome in children (MIS-C). METHODS: This is a cross-sectional retrospective study consisting of pediatric patients diagnosed with MIS-C who were treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Çaǧlayan, Şengül, Sönmez, Hafize Emine, Otar Yener, Gülçin, Baǧlan, Esra, Öztürk, Kübra, Ulu, Kadir, Guliyeva, Vafa, Demirkol, Demet, Çakan, Mustafa, Özdel, Semanur, Bukulmez, Hulya, Aktay Ayaz, Nuray, Sözeri, Betül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433644/
https://www.ncbi.nlm.nih.gov/pubmed/36061383
http://dx.doi.org/10.3389/fped.2022.942455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433644/
https://www.ncbi.nlm.nih.gov/pubmed/36061383
http://dx.doi.org/10.3389/fped.2022.942455

Ejemplares similares